Our Opinion

Longeveron Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following news article that they use animals for product testing.

“LMSCs have multiple mechanisms of action that make them highly attractive candidates for treating neurodegenerative disorders such as AD. Previous animal and human studies have shown this cell type has powerful anti-inflammatory and pro-regenerative properties, and can treat amyloidosis, among many other highly desired properties that would be exactly what one would want for treating AD.” Read the following article

Company Description

Longeveron Inc. is a clinical stage biotechnology company, which is developing cellular therapies for specific aging-related and life-threatening conditions. The Company’s lead investigational product is the LOMECEL-B cell-based therapy product (Lomecel-B), which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors.

Company Website: https://www.longeveron.com